Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]

S. Knop; H. Hebart; A. Gratwohl; C. Kliem; C. Faul; E. Holler; J. Apperley; H. J. Kolb; A. Schaefer; D. Niederwieser; H. Einsele

doi:10.1038/sj.leu.2404731

Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]

S. Knop, H. Hebart, A. Gratwohl, C. Kliem, C. Faul, E. Holler, J. Apperley, H. J. Kolb, A. Schaefer, D. Niederwieser, H. Einsele

Research output: Contribution to journal › Letter › peer-review

25 Scopus citations

Original language	English
Pages (from-to)	1830-1833
Number of pages	4
Journal	Leukemia
Volume	21
Issue number	8
DOIs	https://doi.org/10.1038/sj.leu.2404731
State	Published - Aug 2007
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/sj.leu.2404731

Cite this

Knop, S., Hebart, H., Gratwohl, A., Kliem, C., Faul, C., Holler, E., Apperley, J., Kolb, H. J., Schaefer, A., Niederwieser, D., & Einsele, H. (2007). Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]. Leukemia, 21(8), 1830-1833. https://doi.org/10.1038/sj.leu.2404731

Knop, S. ; Hebart, H. ; Gratwohl, A. et al. / Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone : A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]. In: Leukemia. 2007 ; Vol. 21, No. 8. pp. 1830-1833.

@article{a24f56f0196845e2964a760a081ad477,

title = "Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]",

author = "S. Knop and H. Hebart and A. Gratwohl and C. Kliem and C. Faul and E. Holler and J. Apperley and Kolb, {H. J.} and A. Schaefer and D. Niederwieser and H. Einsele",

year = "2007",

month = aug,

doi = "10.1038/sj.leu.2404731",

language = "English",

volume = "21",

pages = "1830--1833",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "8",

}

Knop, S, Hebart, H, Gratwohl, A, Kliem, C, Faul, C, Holler, E, Apperley, J, Kolb, HJ, Schaefer, A, Niederwieser, D & Einsele, H 2007, 'Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]', Leukemia, vol. 21, no. 8, pp. 1830-1833. https://doi.org/10.1038/sj.leu.2404731

Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]. / Knop, S.; Hebart, H.; Gratwohl, A. et al.
In: Leukemia, Vol. 21, No. 8, 08.2007, p. 1830-1833.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone

T2 - A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]

AU - Knop, S.

AU - Hebart, H.

AU - Gratwohl, A.

AU - Kliem, C.

AU - Faul, C.

AU - Holler, E.

AU - Apperley, J.

AU - Kolb, H. J.

AU - Schaefer, A.

AU - Niederwieser, D.

AU - Einsele, H.

PY - 2007/8

Y1 - 2007/8

UR - http://www.scopus.com/inward/record.url?scp=34447644425&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2404731

DO - 10.1038/sj.leu.2404731

M3 - Letter

C2 - 17495972

AN - SCOPUS:34447644425

SN - 0887-6924

VL - 21

SP - 1830

EP - 1833

JO - Leukemia

JF - Leukemia

IS - 8

ER -

Knop S, Hebart H, Gratwohl A, Kliem C, Faul C, Holler E et al. Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]. Leukemia. 2007 Aug;21(8):1830-1833. doi: 10.1038/sj.leu.2404731

Treatment of steroid-resistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complications when compared to high-dose steroids alone: A randomized multicenter trial by the EBMT Chronic Leukemia Working Party [7]

UN SDGs

Access to Document

Other files and links

Cite this